Lead Product(s): Oxytocin
Therapeutic Area: Obstetrics/Gynecology (Women’s Health) Product Name: ICOone
Highest Development Status: Undisclosed Product Type: Peptide
Partner/Sponsor/Collaborator: Monash University
Deal Size: $1.0 million Upfront Cash: Undisclosed
Deal Type: Collaboration December 21, 2020
The agreement gives Monash an exclusive global right to use ICOone with oxytocin to prevent postpartum haemorrhage in women giving birth.